Viewing StudyNCT00317902



Ignite Creation Date: 2024-05-05 @ 4:47 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00317902
Status: COMPLETED
Last Update Posted: 2011-05-19
First Post: 2006-04-21

Brief Title: An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT Epoetin Alfa Dosing 40000-60000 Units On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients CHAMPS II
Sponsor:
Organization: Ortho Biotech Products LP